MiNK Therapeutics, Inc.
INKT
$8.41
-$0.34-3.89%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -10.78M | -13.78M | -17.09M | -20.59M | -22.46M |
Total Depreciation and Amortization | 215.40K | 215.10K | 206.00K | 212.80K | 204.70K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 554.20K | 952.90K | 3.08M | 3.27M | 3.59M |
Change in Net Operating Assets | 459.80K | 1.75M | 1.72M | 3.17M | 2.90M |
Cash from Operations | -9.56M | -10.86M | -12.08M | -13.94M | -15.76M |
Capital Expenditure | -- | 0.00 | -23.00K | -60.00K | -73.50K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | 0.00 | -23.00K | -60.00K | -73.50K |
Total Debt Issued | 5.00M | 5.00M | 5.00M | 5.00M | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 5.82M | 5.82M | 5.82M | 31.90K | 70.50K |
Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | -97.70K | -477.60K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 10.82M | 10.82M | 10.82M | 4.93M | -407.10K |
Foreign Exchange rate Adjustments | -54.60K | -26.80K | -23.60K | -10.70K | -25.20K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 1.21M | -70.50K | -1.31M | -9.07M | -16.27M |